semaglutide vs tirzepatide efficacy (Zepbound; Eli Lilly and Co) demonstrated 47% greater relative weight loss compared to (Wegovy; Novo Nordisk) in the SURMOUNT-5 phase 3b open-label trial. Full results will be presented at a Frontiers | Tirzepatide vs. semaglutide

Ready to start your medically supervised, results-driven weight loss program delivered 100% virtually

Retrieved from: Uziel, G

Despite a 12.8% decline in deal volume, first-round biotech VC funding rose to $7.7 billiona significant recovery from 2023s $3.8 billion (14)

Non-anesthetic procedures, while not shown to be safer or as thorough as anesthetized cleaning, 117 may be more appropriate in animals for which anesthesia may pose increased risk

MAFLD is defined as hepatic steatosis with metabolic dysregulation, type 2 diabetes mellitus, overweight or obesity, and is characterized by extensive liver lesions, which can progress from isolated steatosis to metabolic dysfunction-associated steatohepatitis (MASH), liver fibrosis, and even HCC